GABBR1 and prostate carcinoma: In other studies, however, GABA B receptor agonists have been shown to have no significant effects on the cell proliferation and/or migration/invasion of colon [40] and liver [41] cancer lines as well as both AR-positive and AR-negative prostate cancer lines [42].